share_log

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

Benzinga Real-time News ·  Aug 22, 2022 19:14
  • The U.S. Food and Drug Administration (FDA) has announced clearance toInsulet's (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D). Insulet shares traded in a range of $260.13 to $266.73 on day volume of 200.86 thousand shares versus three months average volume of 476.99 thousand shares, closed regular trading session at $261.89.
  • Pfizer(NYSE:PFE) andBioNtech SE (NASDAQ:BNTX) have completed a submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals...
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment